Gene · 823
Papers2,391
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,391
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Calpain 2 regulates IL-1α secretion and inhibits tumor development via modulating calpain 1 expression in the tumor microenvironment. | Oncoimmunology | 2025 | 39803956 | PubTator, text mining | PubMed |
| GPR68 supports AML cells through the calcium/calcineurin pro-survival pathway and confers chemoresistance by mediating glucose metabolic symbiosis. | Biochim Biophys Acta Mol Basis Dis | 2025 | 39522891 | PubTator, text mining | PubMed |
| Hereditary Spastic Paraplegia Associated with Ultra-Rare Variant Enrichment Encompassing the SYNE1, CAPN1 and PGAP1 Genes. | Cerebellum | 2024 | 39641820 | PubTator, text mining | PubMed |
| Erratum. Inhibition of motility by NEO100 through the calpain-1/RhoA pathway. | J Neurosurg | 2024 | 39612493 | PubTator, text mining | PubMed |
| Three Iranian patients with rare subtypes of hereditary spastic paraplegia (HSP): SPG76, SPG56, and SPG69. | Neurogenetics | 2024 | 39607444 | PubTator, text mining | PubMed |
| N-terminal cleavage of cyclophilin D boosts its ability to bind F-ATP synthase. | Commun Biol | 2024 | 39528709 | PubTator, text mining | PubMed |
| Calpain-1 weakens the nuclear envelope and promotes the release of neutrophil extracellular traps. | Cell Commun Signal | 2024 | 39252008 | PubTator, text mining | PubMed |
| Testing calpain inhibition in tumor endothelial cells: novel targetable biomarkers against glioblastoma malignancy. | Front Oncol | 2024 | 39156707 | PubTator, text mining | PubMed |
| L-asparaginase induces IP3R-mediated ER Ca2+ release by targeting µ-OR1 and PAR2 and kills acute lymphoblastic leukemia cells. | Cell Death Discov | 2024 | 39147734 | PubTator, text mining | PubMed |
| The Expression of Neurodegeneration-Related Genes in the Hippocampus of Hypothyroid Rats Following Long-Term Potentiation. | Eurasian J Med | 2024 | 39128046 | PubTator, text mining | PubMed |
| Integrated metabolomics and transcriptomics analysis reveals the mechanism of Tangbi capsule for diabetic lower extremities arterial disease. | Front Microbiol | 2024 | 39104587 | PubTator, text mining | PubMed |
| A plasma peptidomic signature reveals extracellular matrix remodeling and predicts prognosis in alcohol-associated hepatitis. | Hepatol Commun | 2024 | 39082970 | PubTator, text mining | PubMed |
| Dissecting the multifaceted roles of autophagy in cancer initiation, growth, and metastasis: from molecular mechanisms to therapeutic applications. | Med Oncol | 2024 | 38902544 | PubTator, text mining | PubMed |
| Otud6b induces pulmonary arterial hypertension by mediating the Calpain-1/HIF-1α signaling pathway. | Cell Mol Life Sci | 2024 | 38878112 | PubTator, text mining | PubMed |
| Novel Genetic Variants Associated with Primary Myocardial Fibrosis in Sudden Cardiac Death Victims. | J Cardiovasc Transl Res | 2024 | 38848015 | PubTator, text mining | PubMed |
| A Cyclometalated Ruthenium(II) Complex Induces Oncosis for Synergistic Activation of Innate and Adaptive Immunity. | Angew Chem Int Ed Engl | 2024 | 38771671 | PubTator, text mining | PubMed |
| Formation of the calpain-1/calpastatin complex promotes activation of calpain-1 under oxidizing conditions. | J Anim Sci | 2024 | 38738874 | PubTator, text mining | PubMed |
| Sunitinib malate induces cell death in adult human cardiac progenitor cells. | Curr Res Toxicol | 2024 | 38659494 | PubTator, text mining | PubMed |
| Functional properties and skin care effects of sodium trehalose sulfate. | Skin Res Technol | 2024 | 38606717 | PubTator, text mining | PubMed |
| Reversible Covalent Inhibition─Desired Covalent Adduct Formation by Mass Action. | ACS Chem Biol | 2024 | 38567529 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/823/papers?page=5